Experimental cancer drug enters first human trials

NCT ID NCT06466187

Ongoing Disease control Sponsor: Seagen, a wholly owned subsidiary of Pfizer Source: ClinicalTrials.gov ↗

Summary

This early-stage study is testing a new experimental drug called SGN-MesoC2 in people with advanced solid tumors that have stopped responding to standard treatments. The main goal is to find the safest dose and understand how the drug behaves in the body. The study includes 19 participants with various advanced cancers including lung, ovarian, pancreatic, and colorectal cancers.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Locations

Atrium Health Wake Forest Baptist

Winston-Salem, North Carolina, 27157, United States
McGill University Health Centre

Montreal, Quebec, H4A 3J1, Canada
SCRI Oncology Partners

Nashville, Tennessee, 37203, United States
START Mountain Region

West Valley City, Utah, 84119, United States
START Mountain Region, LLC

Salt Lake City, Utah, 84119, United States
START San Antonio, LLC

San Antonio, Texas, 78229, United States
Sarah Cannon Research Institute - Pharmacy

Nashville, Tennessee, 37203, United States
The Board of Trustees of the University of Alabama for the University of Alabama at Birmingham

Birmingham, Alabama, 35294, United States
The Research Institute of the McGill University Health Centre

Montreal, Quebec, H3H 2R9, Canada
The University of Alabama at Birmingham

Birmingham, Alabama, 35249, United States
The University of Kansas Cancer Center - Indian Creek Campus

Overland Park, Kansas, 66211, United States
The University of Kansas Cancer Center - Westwood

Westwood, Kansas, 66205, United States
The University of Kansas Cancer Center, Investigational Drug Services

Westwood, Kansas, 66205, United States
The University of Kansas Clinical Research Center

Fairway, Kansas, 66205, United States
The University of Kansas Hospital

Kansas City, Kansas, 66160, United States
The University of Kansas Hospital Cambridge North Tower A

Kansas City, Kansas, 66160, United States
The University of Kansas Medical Center Medical Office Building

Kansas City, Kansas, 66160, United States
University Health Network

Toronto, Ontario, M5G 2C4, Canada
University Health Network, Princess Margaret Cancer Centre

Toronto, Ontario, M5G 2M9, Canada
University of Alabama at Birmingham

Birmingham, Alabama, 35233, United States
University of Alabama at Birmingham

Birmingham, Alabama, 35249, United States

Conditions

Explore the condition pages connected to this study.

CARCINOMA, NON-SMALL-CELL LUNG COLORECTAL NEOPLASMS ENDOMETRIAL MESOTHELIOMA OTHER SOLID TUMORS OVARIAN NEOPLASMS PANCREATIC ADENOCARCINOMA